Mcm2, Geminin, and KI67 define proliferative state and are prognostic markers in renal cell carcinoma.

Mcm2, Geminin, and KI67 define proliferative state and are prognostic markers in renal cell carcinoma.

PURPOSE: The origin licensing factors minichromosome maintenance 2 (Mcm2) and Geminin have recently been identified as critical regulators of growth and differentiation. Here we have investigated the regulation of these licensing factors together with Ki67 to further elucidate the cell cycle kineti...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Dudderidge, T, Stoeber, K, Loddo, M, Atkinson, G, Fanshawe, T, Griffiths, D, Williams, G
Μορφή:	Journal article
Γλώσσα:	English
Έκδοση:	2005

Παρόμοια τεκμήρια

Repression of DNA replication licensing in quiescence is independent of geminin and may define the cell cycle state of progenitor cells.
ανά: Kingsbury, SR, κ.ά.
Έκδοση: (2005)

Ki-67 and MCM-2 in Dental Follicle and Odontogenic Cysts: The Effects of Inflammation on Proliferative Markers
ανά: Nurhan Güler, κ.ά.
Έκδοση: (2012-01-01)

Correlation of Ki-67 and MCM-2 proliferative marker expression with grade of histological malignancy (G) in ductal breast cancers.
ανά: Marzena Podhorska-Okolow, κ.ά.
Έκδοση: (2010-11-01)

MCM3 proliferative index is worthier over Ki-67 in the characterization of salivary gland tumors
ανά: Ritika Raja, κ.ά.
Έκδοση: (2021-01-01)

MCM3 and Ki67 proliferation markers in odontogenic cysts and ameloblastoma
ανά: Zohreh Jaafari-Ashkavandi, κ.ά.
Έκδοση: (2019-01-01)

Tumor size and proliferative marker geminin rather than Ki67 expression levels significantly associated with maximum uptake of 18F-deoxyglucose levels on positron emission tomography for breast cancers.
ανά: Arisa Nishimukai, κ.ά.
Έκδοση: (2017-01-01)

Prognostic impact of Ki‐67 proliferative index in resectable pancreatic ductal adenocarcinoma
ανά: I. Pergolini, κ.ά.
Έκδοση: (2019-10-01)

Gene experison of cell proliferative marker Ki67 in breast cancer
ανά: Golmohammadi R (PhD), κ.ά.
Έκδοση: (2011-09-01)

Cutaneous Canine Mast Cell Tumor: The Use of Proliferative Markers (Ki-67 and Ki-67 × AgNOR) in Cytological Samples for Diagnosis and Prognosis
ανά: Christina Marouda, κ.ά.
Έκδοση: (2024-01-01)

Evaluation of Nuclear Morphometry and Ki-67 Proliferative Marker in Astrocytomas: An Ambispective Study
ανά: Palak Nanda, κ.ά.
Έκδοση: (2023-01-01)

A study on the role of proliferative index marker Ki67 in breast carcinoma
ανά: Vijetha Vikram, κ.ά.
Έκδοση: (2022-11-01)

Expression of Progestrone Receptor and Proliferative Marker ki 67, in Various Grades of Meningioma
ανά: Nasrin Shayanfar, κ.ά.
Έκδοση: (2010-06-01)

Expression of Progestrone Receptor and Proliferative Marker ki 67, in Various Grades of Meningioma
ανά: Nasrin Shayanfar, κ.ά.
Έκδοση: (2010-05-01)

Prognostic significance of MCM2, Ki-67 and gelsolin in non-small cell lung cancer
ανά: Huberman Joel, κ.ά.
Έκδοση: (2006-08-01)

MCM - 2 and Ki - 67 as proliferation markers in renal cell carcinoma: A quantitative and semi - quantitative analysis
ανά: Muhammad Zain Mehdi, κ.ά.

Histopathological and Immunohistochemical Evaluation of Meningiomas with Reference to Proliferative Markers p53 and Ki-67
ανά: Ramesh Babu Telugu, κ.ά.
Έκδοση: (2016-01-01)

Proliferative activity in human breast cancer: Ki-67 automated evaluation and the influence of different Ki-67 equivalent antibodies
ανά: Gasperetti F, κ.ά.
Έκδοση: (2011-03-01)

Expression of proliferative marker Ki-67 in epithelial dysplasia and squamous cell carcinoma of oral cavity
ανά: Payal Doctor, κ.ά.
Έκδοση: (2023-04-01)

Ki-67 expression is superior to mitotic count and novel proliferation markers PHH3, MCM4 and mitosin as a prognostic factor in thick cutaneous melanoma
ανά: Bachmann Ingeborg M, κ.ά.
Έκδοση: (2010-04-01)

Comment on “PCNA and Ki67: Prognostic proliferation markers for oral cancer”
ανά: Muthupandian Saravanan
Έκδοση: (2024-06-01)

Expression of Ki67 as a Prognostic Marker in Invasive Breast Carcinoma
ανά: Rashi Ahuja, κ.ά.
Έκδοση: (2017-07-01)

Association of degree of expression of ki 67 proliferative cell marker with aggressive giant cell tumor of the bone
ανά: Wan Faisham Nu Man, Wan Ismail
Έκδοση: (2013)

Geminin is required for the maintenance of pluripotency.
ανά: Golnaz A Tabrizi, κ.ά.
Έκδοση: (2013-01-01)

MCM6 versus Ki-67 in diagnosis of luminal molecular subtypes of breast cancers
ανά: Dorsay Sadeghian, κ.ά.
Έκδοση: (2022-02-01)

Evaluation of the Ki-67 and MCM3 Expression in Cytologic Smear of Oral Squamous Cell Carcinoma
ανά: Fahimeh Rezazadeh, κ.ά.
Έκδοση: (2017-09-01)

KI-67 AS A PROGNOSTIC FACTOR OF MYELODYSPLASTIC SYNDROME
ανά: G.S. Starodub, κ.ά.
Έκδοση: (2016-04-01)

The expression of Ki-67 marker in the hydatidiform mole
ανά: Ecaterina Carpenco, κ.ά.
Έκδοση: (2022-12-01)

Evaluation of the proliferation marker Ki67 as a prognostic factor in patients with breast carcinoma
ανά: Fatima S. Al-Sarraf, κ.ά.
Έκδοση: (2015-07-01)

The importance of prognostic markers of tumor progression Ki-67 and р53 in the breast cancer
ανά: Bondareva V.A., κ.ά.
Έκδοση: (2007-01-01)

P53 and Ki-67 as prognostic markers in triple-negative breast cancer patients.
ανά: Yunbao Pan, κ.ά.
Έκδοση: (2017-01-01)

Clinicopathologic study and Ki-67 proliferative marker evaluation in human osteosarcomas Estudo clinicopatológico com avaliação do índice de proliferação celular avaliado pelo Ki-67 em osteossarcomas humanos
ανά: Larissa Cardoso Marinho, κ.ά.
Έκδοση: (2005-12-01)

Mitogenic growth signalling, DNA replication licensing, and survival are linked in prostate cancer.
ανά: Dudderidge, T, κ.ά.
Έκδοση: (2007)

Irisin Association with Ki-67, MCM3 and MT-I/II in Squamous Cell Carcinomas of the Larynx
ανά: Agnieszka Pinkowska, κ.ά.
Έκδοση: (2021-12-01)

Predictive Role of Ki-67 and Proliferative-Cell Nuclear Antigen (PCNA) in Recurrent Cholesteatoma
ανά: Ela Araz Server, κ.ά.
Έκδοση: (2019-04-01)

Proliferative activity of myeloma cells determined by Ki-67 antibody: Biological and clinical significance
ανά: Marković Olivera, κ.ά.
Έκδοση: (2005-01-01)

Association of the Estrogen Receptors Beta Expression with the Ki-67 Proliferative Index in Breast Cancer
ανά: T. A. Bogush, κ.ά.
Έκδοση: (2023-07-01)

Assessment of Ki-67 Proliferative Index in Cytological Samples of Nodal B-Cell Lymphomas
ανά: Mojca Založnik, κ.ά.
Έκδοση: (2024-07-01)

Role of Proliferative Marker (Ki-67) and ER, PR in Cervical Epithelial Lesions with Clinicopathological Association: A Cross-sectional Study
ανά: Shrabani Mitra, κ.ά.
Έκδοση: (2025-02-01)

MCM-2, Ki-67, and EGFR downregulated expression levels in advanced stage laryngeal squamous cell carcinoma
ανά: Sarocha Vivatvakin, κ.ά.
Έκδοση: (2021-07-01)

Prognostic Significance of Bcl-2 and p53 Protein Expressions and Ki67 Proliferative Index in Diffuse Large B-cell Lymphoma
ανά: Betül Bolat Küçükzeybek, κ.ά.
Έκδοση: (2013-09-01)